Target intelligence / Profile preview

Ribulose-5-phosphate-3-epimerase pseudogene 3 (RPEP3)

Target
RPEP3
Molecular classification
Other (pseudogene)
01

Overview

RPEP3 (ribulose-5-phosphate-3-epimerase pseudogene 3) is annotated as a *pseudogene* in the human genome, with Gene ID 100420555[3]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they typically arise from gene duplication or retrotransposition and lack the ability to encode functional proteins. Unlike the protein-coding gene RPE (ribulose-5-phosphate 3-epimerase), which is an enzyme involved in the pentose phosphate pathway and Calvin cycle[2][4], RPEP3 does not code for an active enzyme and is not considered a drug target, disease biomarker, or therapeutic agent. There is no evidence for a functional role, disease association, or drug targeting for RPEP3[3]. Key clarifications: - RPEP3 is *not* a protein-coding gene; it is a pseudogene in humans[3]. - There is *no known biological function*, *disease association*, or *therapeutic relevance*. - It should not be confused with "ribulose-5-phosphate 3-epimerase" (abbreviated as RPE), which is a functional enzyme involved in core metabolic pathways[2][4]. - Because pseudogenes are generally non-functional and not involved in therapeutic drug targeting, *is_target* is **false** and *is_incorrect* is **true** for a therapeutic target list. If you need information about the **active enzyme** ("ribulose-5-phosphate 3-epimerase" / RPE), please specify, as that is a biochemically and therapeutically distinct entity[2][4].

Other names
ribulose 5-phosphate 3-epimerase pseudogene 3

Beyond the preview

Go deeper on Ribulose-5-phosphate-3-epimerase pseudogene 3 (RPEP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribulose-5-phosphate-3-epimerase pseudogene 3 (RPEP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call